Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Helicobacter Infections 2Gastroesophageal Reflux 2Barrett Esophagus 2Spinal Cord Compression 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Non-Erosive Reflux Disease 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Gastritis, Atrophic 1Fatigue 1Familial primary gastric lymphoma 1Esophageal Neoplasms 1Delayed Bleeding 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Proton Pump Inhibitors 2Vitamin D 1Therapeutics 1Rabeprazole 1Probiotics 1Pantoprazole 1Observation 1Lansoprazole 1Dexlansoprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Helicobacter Infections × Proton Pump Inhibitors × Clear all
NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

NCT02449941 2016-12-06

Helicobacter Pylori and Proton Pump Inhibitor

Asan Medical Center

Completed
30 enrolled
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms, Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡